Related Experiment Video
Updated: Feb 21, 2026

07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.5K
Students' Satisfaction with a Web-Based Pharmacy Program in a Re-Regulated Pharmacy Market.
Maria Gustafsson1, Sofia Mattsson2, Gisselle Gallego3
1Department of Pharmacology and Clinical Neuroscience, Umeå University, SE-90187 Umeå, Sweden. maria.gustafsson@umu.se.
Pharmacy (Basel, Switzerland)
|October 4, 2017
Summary
Graduates of Umeå University
Area of Science:
- Pharmacy Education
- Higher Education
- Distance Learning
Background:
- A web-based Bachelor of Science in Pharmacy program was established at Umeå University in 2003 to address pharmacist shortages in Northern Sweden.
- The Swedish pharmacy market was re-regulated in 2009, transitioning from a state monopoly to an open market.
- The impact of this market re-regulation on pharmacy education satisfaction was previously unknown.
Purpose of the Study:
- To assess graduate satisfaction with the web-based pharmacy program.
- To identify desired changes in curriculum content and skills.
- To compare satisfaction levels before and after the Swedish pharmacy market re-regulation.
Main Methods:
- A cross-sectional survey was conducted in 2015 among alumni who graduated between 2006 and 2014.
- Responses from 200 graduates regarding program satisfaction were analyzed.
- Statistical analysis was used to compare satisfaction levels pre- and post-market re-regulation.
Main Results:
- 88% of graduates found their acquired knowledge and skills useful in their current employment.
- Graduates desired more applied pharmacy practice and self-care counselling, and less social pharmacy and histology.
- 82% would choose the program again, and 92% would recommend it.
Conclusions:
- Pharmacy graduates reported high satisfaction with the web-based program.
- The re-regulation of the Swedish pharmacy market did not negatively impact program satisfaction.
- Alumni satisfaction and program recommendation rates were higher after the market re-regulation.
Related Concept Videos
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
25
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
25
Drug Control Governance: Regulatory Bodies and Their Impact
594
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
594
Dosage Regimens: Partial Pharmacokinetic Parameters
204
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
204
Modified-Release Drug Delivery Systems: Rate-Programmed II
38
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
38

